iProtics
Leiden
About iProtics
iProtics is revolutionizing the treatment of cancer and auto-immune disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $383.0K
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2024)
- Website: iprotics.eu
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/iprotics-122981 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.